Specific Immunoglobulins

Name
Specific Immunoglobulins
Accession Number
DBCAT002142
Description
Not Available
ATC Classification
Drugs
DrugDrug Description
PalivizumabA monoclonal anti respiratory syncytial virus F protein antibody used to prevent serious sequelae caused by respiratory syncytial virus infection in pediatric patients.
MotavizumabInvestigated for use/treatment in viral infection and pediatric indications.
RaxibacumabA monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate.
Tetanus Immune GlobulinA solution of antibodies used to prevent tetanus after an injury.
Human cytomegalovirus immune globulinA solution of immune globulin G against cytomegalovirus used to prevent transmission of cytomegalovirus after organ transplants.
ObiltoxaximabA monoclonal antibody used for prophylaxis or treatment of inhalational anthrax.
BezlotoxumabA monoclonal antibody used to reduce the recurrence of Clostridium difficile infections.
Drugs & Drug Targets
DrugTargetType
PalivizumabFusion glycoprotein F0target
PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
PalivizumabComplement C1r subcomponenttarget
PalivizumabComplement C1q subcomponent subunit Atarget
PalivizumabComplement C1q subcomponent subunit Btarget
PalivizumabComplement C1q subcomponent subunit Ctarget
PalivizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
PalivizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
PalivizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
RaxibacumabProtective antigentarget
Tetanus Immune GlobulinTetanus toxintarget
BezlotoxumabClostridium difficile Toxin Btarget